What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001420995
Total reported value
$467.8M
$467.8M
9 檔
147.6%
As reported in its official Q2 2025 Form 13F filing, Trustees of Columbia University in the City of New York's tracked investment portfolio stood at $467.8M with 9 total positions.
Trustees of Columbia University in the City of New York executed strategic sector rebalancing during Q2 2025, establishing 1 new positions while fully exiting 2 holdings and trimming 0 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 99.50% | -1.24% | +0.29% | |
| 2 | VIGL | Vigil Neuroscience Inc | Stock-Other | 0.22% | — | — | |
| 3 | HEI-A | Heico Corp-class A | Stock-Other | 0.12% | — | — | |
| 4 | SRZN | Surrozen Inc | Stock-Other | 0.06% | — | — | |
| 5 | QTTB | Q32 Bio Inc | Stock-Other | 0.03% | — | — | |
| 6 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 0.03% | — | — | |
| 7 | ✓ | Xilio Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 8 | VOR | Vor Biopharma Inc. | Stock-Other | 0.02% | — | — | |
| 9 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +1.2% | +0.29% | Add |
| 2 | VIGL | Vigil Neuroscience Inc | +0.2% | — | Unchanged |
| 3 | HEI-A | Heico Corp-class A | +0.1% | NEW | New buy |
| 4 | VOR | Vor Biopharma Inc. | 0% | — | Unchanged |
| 5 | TNYA | Tenaya Therapeutics Inc | — | — | Unchanged |
| 6 | SRZNW | Surrozen Inc-cw25 | — | — | Unchanged |
| 7 | ✓ | Rapt Therapeutics Inc | 0% | EXIT | Sold out |
| 8 | QTTB | Q32 Bio Inc | 0% | — | Unchanged |
| 9 | ✓ | Xilio Therapeutics Inc | 0% | — | Unchanged |
| 10 | SRZN | Surrozen Inc | 0% | — | Unchanged |
| 11 | NU | Nu Holdings Ltd. | -1.5% | EXIT | Sold out |
According to official SEC Form 13F filings, Trustees of Columbia University in the City of New York reported a total U.S. public equity portfolio value of $467.8M across 9 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, VIGL, HEI-A) accounted for 147.6% of total reported equity market value during Q2 2025.
Top New Position Initiated
HEI-A
市值: $824.6K
Top Position Liquidated / Trimmed
NU
前期市值: $9.3M
During Q2 2025, Trustees of Columbia University in the City of New York's top holdings by market value included SPY (99.5%)、VIGL (0.2%)、HEI-A (0.1%). The largest single position, SPY, represented 99.5% of total portfolio value.
In Q2 2025, Trustees of Columbia University in the City of New York made 4 total portfolio adjustments, initiating 1 new buys, adding to 1 positions, trimming 0 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.